Fundraising FoxAgemica
1 known investors
Find your way into Agemica
Sign up to find every way you can get introduced to Agemica
- Your email: who you already know at Agemica, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Agemica team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Agemica uses AI to rank disease mechanisms across omics data, targets, and safe-drug libraries, then tests predicted drug combinations in ex-vivo human cancer models to measure cancer-cell death, tumor-volume reduction, and healthy-cell safety. The company advances the strongest candidates toward humanized-mouse studies, IND-enabling work, and clinical development in the AI drug discovery and oncology space.
Founders & leadership
Investors · 1
Frequently asked questions
- What does Agemica do?
- Agemica uses AI to rank disease mechanisms across omics data, targets, and safe-drug libraries, then tests predicted drug combinations in ex-vivo human cancer models to measure cancer-cell death, tumor-volume reduction, and healthy-cell safety. The company advances the strongest candidates toward humanized-mouse studies, IND-enabling work, and clinical development in the AI drug discovery and oncology space.
- Who founded Agemica?
- Agemica was founded by Yasaman KalantarMotamedi.
- Who are Agemica's investors?
- Agemica's investors include Valkyrie.